20th September 2019 by Louise Hudman
This is a new guideline from NICE giving advice on ertugliflozin, published in April 2019. I am also doing a quick reminder about the other SGLT-2 inhibitors.
It is another sodium-glucose co-transporter 2 (SGLT-2) inhibitor, like canagliflozin, dapagliflozin and empagliflozin.
It is thought to be as effective as the other SGLT-2 inhibitors, but it is cheaper.
Preventing type 2 diabetes: guidance for GPs (SIGN, 2025)
This is a new guideline from SIGN on preventing Type 2 Diabetes. It was published in March 2025.
Video: Dr Varun Anand – adult obesity and weight management
Dr Varun Anand gives a webinar on adult obesity and weight management in general practice.
Breaking bad news to patients: a sessional GP’s guide
Dr Sabira Hughes and Dr Priyanka Saigal, Medicolegal Consultants at Medical Protection, describe situations when GP locums might be required to break bad news, why it is important to be good at breaking bad news, the consequences of getting it right or wrong, and frameworks GP locums can use to break bad news.
"I have tried a few different platforms but nothing compares to the comfort and practicality of LocumDeck. The NASGP support team is absolutely wonderful and they walked me through the initial set-up. Once the set-up is complete, the booking process is so easy and literally happens with the click of a button. I also love the paperless pension form submissions through LocumDeck and it takes me no more than two minutes each month to send all the necessary pension forms to PCSE. I have already recommended LocumDeck to all my colleagues and it is a must-have for anyone thinking about entering the GP locum world. I wish every practice in the country would sign up."
Dr Priya Arunachalam, GP, Southampton